Search for: "Reckitt Benckiser Inc." Results 1 - 20 of 53
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 May 2014, 7:00 am by Gene Quinn
The license agreement grants Reckitt Benckiser Pharmaceuticals Inc., a wholly owned subsidiary of Reckitt Benckiser Group plc, rights for the development and commercialization of XenoPort's promising oral treatment for alcohol use disorders, a condition affecting more than 140 million people worldwide. [read post]
16 May 2014, 7:00 am by Gene Quinn
The license agreement grants Reckitt Benckiser Pharmaceuticals Inc., a wholly owned subsidiary of Reckitt Benckiser Group plc, rights for the development and commercialization of XenoPort's promising oral treatment for alcohol use disorders, a condition affecting more than 140 million people worldwide. [read post]
24 Aug 2015, 9:55 pm by Patent Docs
Reddys Laboratories, Inc. et al. 1:15-cv-04524; filed June 26, 2015 in the District Court of New Jersey • Plaintiff: Reckitt Benckiser LLC • Defendants: Reckitt Benckiser LLC; Dr. [read post]
7 Dec 2014, 9:03 pm by Patent Docs
Reckitt Benckiser Pharmaceuticals Inc. et al. v. [read post]
21 Sep 2014, 9:01 pm by Patent Docs
Reckitt Benckiser LLC v. [read post]
11 Jul 2019, 4:47 pm by Ben Vernia
(then known as Reckitt Benckiser Pharmaceuticals Inc.) marketed and sold Suboxone throughout the United States. [read post]
31 Jul 2020, 2:11 pm by luiza
This is in addition to the $1.4 billion resolution with Indivior’s former parent, Reckitt Benckiser Group PLC (“RB Group”) that was previously announced in 2019. [read post]
11 Sep 2015, 4:00 am by Alan Macek
Reckitt Benckiser LLC, 2015 FCA 104 affirming the decision of Justice Brown (2015 FC 215), related to the enforcement of the plaintiff’s MEGARED trade-mark against the defendant’s OMEGARED product. [read post]
19 Feb 2024, 2:15 pm by Dr. Shezad Malik
District Court for the Eastern District of New York, against the drug manufacturers Indivior Inc., Aquestive Therapeutics Inc, Monosol Rx In., and Reckitt Benckiser LLC. [read post]
8 Jul 2011, 1:13 pm by Phil
In 2009, Reckitt Benckiser Inc. sued Watson Laboratories, Inc. - Florida for patent infringement related to Watson's filing of three Abbreviated New Drug Applications for generic versions of Reckitt's Mucinex(R) line of products. [read post]
31 Jul 2017, 9:21 am by Phyllis H. Marcus
NAD Recommends Reckitt Benckiser Discontinue Certain Claims The NAD has recommended that Reckitt Benckiser LLC also discontinue claims that its Amope GelActiv Insoles offer “improved comfort” while wearing high heels. [read post]
NAD Recommends Reckitt Benckiser Discontinue Certain Claims The NAD has recommended that Reckitt Benckiser LLC also discontinue claims that its Amope GelActiv Insoles offer “improved comfort” while wearing high heels. [read post]